Medium to long-term clinical outcome following stentless aortic valve replacement: Comparison between allograft and xenograft valves

Interactive Cardiovascular and Thoracic Surgery

Volumn 11, Issue 2, 2010, Pages 166-170

  Ali, Ayyaz ^a   Patel, Amit ^a   Ali, Ziad ^a   Abu Omar, Yasir ^a   Freed, Darren ^a   Saeed, Amber ^a   Athanasiou, Thanos ^a   Pepper, John ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

Author keywords

Allografts; Aortic valve replacement; Stentless valves

Indexed keywords

CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ADULT; AGE; AGED; ALLOGRAFT; AORTA STENOSIS; AORTA VALVE PROSTHESIS; AORTA VALVE REGURGITATION; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL CLASSIFICATION; COMPARATIVE STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DRUG USE; ECHOCARDIOGRAPHY; EMERGENCY SURGERY; FUNCTIONAL STATUS; HEART LEFT VENTRICLE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE MASS; HEMODYNAMICS; HUMAN; LEFT VENTRICULAR END DIASTOLIC DIMENSION; LEFT VENTRICULAR END SYSTOLIC DIMENSION; MAJOR CLINICAL STUDY; MALE; MIXED VALVE DISEASE; NEW YORK HEART ASSOCIATION CLASS; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; REOPERATION; SINUS RHYTHM; STENTLESS PORCINE VALVE; STRUCTURAL VALVE DETERIORATION; SURGICAL TECHNIQUE; SURVIVAL; TREATMENT OUTCOME; VALVULAR HEART DISEASE; XENOGRAFT; ALLOTRANSPLANTATION; ANIMAL; AORTA VALVE; BIOPROSTHESIS; ECHOGRAPHY; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; KAPLAN MEIER METHOD; MIDDLE AGED; PROPORTIONAL HAZARDS MODEL; PROSTHESIS; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SWINE; TIME; UNITED KINGDOM; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANIMALS; AORTIC VALVE; BIOPROSTHESIS; FEMALE; HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; KAPLAN-MEIER ESTIMATE; LONDON; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSTHESIS DESIGN; REOPERATION; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SWINE; TIME FACTORS; TRANSPLANTATION, HETEROLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 77957368733     PISSN: 15699293     EISSN: None     Source Type: Journal    
DOI: 10.1510/icvts.2009.219568     Document Type: Article

References (15)

1. Walther T, Falk V, Langebartels G, Kruger M, Bernhardt U, Diegeler A, Gummert J, Autschbach R, Mohr FW. Prospectively randomized evaluation of stentless versus conventional biologic aortic valves: impact on early regression of left ventricular hypertrophy. Circulation 1999; 100:278-283.
2. Ross DN. Homograft replacement of the aortic valve. Lancet 1962;2:487.
3. O'Brien MF, Harrocks S, Stafford EG, Gardner MA, Pohlner PG, Tesar PK, Stephens F. The homograft aortic valve: a 29 year, 99.3% follow up of 1,022 valve replacements. J Heart Valve Dis 2001;10:334-344; discussion 335
4. Lund O, Chandrasekaran V, Grocott-Mason R, Elwidaa H, Mazhar R, Khagani A, Mitchell A, Ilsey C, Yacoub M. Primary aortic valve replacement with allografts over twenty-five years: valve-related and procedure-related determinants of outcome. J Thorac Cardiovasc Surg 1999;117:77-90.
5. Langley SM, McGuirk SP, Chaudhry MA, Livesey SA, Ross JK, Monro JL. Twenty-year follow-up of aortic valve replacement with antibiotic sterilized homografts in 200 patients. Semin Thorac Cardiovasc Surg 1999;11:28-34.
6. Ali A, Lim E, Halstead J, Ashrafian H, Ali Z, Khalpey Z, Theodorou P, Chamageorakis T, Kumar P, Jackson C, Pepper J. Porcine or human stentless valves for aortic valve replacement? Results of a 10-year comparative study. J Heart Valve Dis 2003;12:430-435; discussion 435.
7. Rajappan K, Melina G, Bellenger NG, Amrani M, Khaghani A, Pennell DJ, et al. Evaluation of left ventricular function and mass after Medtronic Freestyle versus homograft aortic root replacement using cardiovascular magnetic resonance. J Heart Valve Dis 2002;11:60-65.
8. Melina G, Mitchell A, Amrani M, Khaghani A, Yacoub MH. Transvalvular velocities after full aortic root replacement: results from a prospective randomized trial between the homograft and the Medtronic Freestyle bioprosthesis. J Heart Valve Dis 2002;11:54-58.
9. Edmunds LH Jr, Clark RE, Cohn LH, Grunkemeier GL, Miller DC, Weisel RD. Guidelines for reporting morbidity and mortality after cardiac valvular operations. Ad hoc lison committee for standardizing definitions of prosthetic heart valve morbidity of the American Association for Thoracic Surgery and the Society of Thoracic Surgeons. J Thorac Cardiovasc Surg 1996;112:708-711.
10. Ali A, Abu-Omar Y, Patel A, Ali Z, Sheikh AY, Akhtar A, Pavlovic A, Theodorou P, Athanasiou T, Pepper J. Valve failure following homograft aortic valve replacement: does implantation technique have an effect? Eur Heart J 2008;29:1454-1462.
11. Bach DS, Metras JS, Doty JR, Yun KL, Dumesnil JG, Kon ND. Freedom from structural valve deterioration among patients aged - or s60 years undergoing Freestyle stentless aortic valve replacement. J Heart Valve Dis 2007;16:649-655.
12. Pavoni D, Badano LP, Ius F, Mazzaro E, Frassani R, Gelsomino S, Livi U. Limited long-term durability of the cyrolife O'Brien stentless porcine xenograft valve. Circulation 2007;116:I307-I313.
13. Gross C, Harringer W, Beran H, Mair R, Sihorsch K, Hoffman R, Brucke P. Aortic valve replacement: is the stentless xenograft an alternative to the homograft? Midterm results. Ann Thorac Surg 1999;68:919-924.
14. Dagenais F, Cartier P, Voisine P, Desaulniers D, Perron J, Baillot R, Raymond G, Metras J, Doyle D, Mathieu P. Which biologic valve should we select for the 45 and 65 year old age group requiring aortic valve replacement. J Thorac Cardiovasc Surg 2005;129:1041-1049.
15. Dellgren G, Eriksson MJ, Brodin LA, Radegran K. Eleven years' experience with the Biocor stentless aortic bioprosthesis: clinical and hemodynamic follow-up with long-term relative survival rate. Eur J Cardiothorac Surg 2002;22:912-921.